Affinia Therapeutics Appoints Hideo Makimura, M.D., Ph.D., as Chief Medical Officer

Seasoned physician-scientist and R&D executive with significant early- and late-stage drug development experience across multiple therapeutic areas including cardiovascular and neuroscience diseases Brings a successful track record of more than 12 Investigational New Drug and Clinical…